Stewart spokeswoman Allyn Magrino said lawyers delivered "over a thousand pages of documents" to Capitol Hill. The documents were received less than an hour before a 5 p.m. EDT Tuesday deadline set by a House Energy and Commerce investigative subcommittee that is probing Stewart's stock sale.
The records included e-mail messages from Stewart's laptop computer and telephone records from Stewart's company, Martha Stewart Living Omnimedia Inc.
"They've assured us they provided everything, but we won't know that until we've had an opportunity to review all the documents," said Ken Johnson, spokesman for the committee. That could take at least two weeks, he said.
Lawmakers are trying to determine if Stewart, prior to her stock sale, had information that the Food and Drug Administration was going to reject ImClone's new colon cancer drug. The company's stock subsequently plummeted. Questions remain despite an earlier letter from Stewart's lawyers denying any advance notice of the FDA's decision, said Rep. James Greenwood, R-Pa., chairman of the investigative subcommittee.
"We feel obligated to find out if she was being straight with us or not," he said.
Stewart has maintained she had an order to sell her stock when it dropped below $60 per share. The committee wants to clear up discrepancies about her account of the sale and those of her broker and assistant.
Copyright 2002. Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
